nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Correction of glycosylated oxyhemoglobin-induced impairment of endothelium-dependent vasodilatation by gliclazide
|
Vallejo, Susana |
|
2000 |
14 |
4 |
p. 207-214 8 p. |
artikel |
2 |
Diamicron®MR once daily is effective and well tolerated in type 2 diabetes: a double-blind, randomized, multinational study
|
Drouin, P |
|
2000 |
14 |
4 |
p. 185-191 7 p. |
artikel |
3 |
Effect of gliclazide on monocyte–endothelium interactions in diabetes
|
Renier, Geneviève |
|
2000 |
14 |
4 |
p. 215-223 9 p. |
artikel |
4 |
In vitro and in vivo antioxidant properties of gliclazide
|
O'Brien, Richard C |
|
2000 |
14 |
4 |
p. 201-206 6 p. |
artikel |
5 |
New insights into metabolic and vascular management of type 2 diabetes
|
Keen, Harry |
|
2000 |
14 |
4 |
p. 179- 1 p. |
artikel |
6 |
Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes
|
Tooke, J.E |
|
2000 |
14 |
4 |
p. 197-200 4 p. |
artikel |
7 |
Prevention of endothelial dysfunction in streptozotocin-induced diabetic rats by gliclazide treatment
|
Vallejo, Susana |
|
2000 |
14 |
4 |
p. 224-233 10 p. |
artikel |
8 |
Therapeutic objectives and their practical achievement in type 2 diabetes
|
Keen, Harry |
|
2000 |
14 |
4 |
p. 180-184 5 p. |
artikel |
9 |
Tissue-specific effects of sulfonylureas
|
Ashcroft, Frances M |
|
2000 |
14 |
4 |
p. 192-196 5 p. |
artikel |